Loukas Y L, Vraka V, Gregoriadis G
Centre for Drug Delivery Research, School of Pharmacy, University of London, UK.
J Pharm Pharmacol. 1997 Feb;49(2):127-30. doi: 10.1111/j.2042-7158.1997.tb06765.x.
The non-linear least-squares model for calculation of the stability constant (Kst) of a drug-cyclodextrin complex has been used in fluorimetry studies. Complexation of riboflavin with beta-cyclodextrin (beta-CyD) was monitored fluorimetrically by measuring changes in the fluorescence intensity of the vitamin in the presence of various amounts of beta-CyD. Formation of an inclusion complex was confirmed in the solid state by differential scanning calorimetry (DSC) and in aqueous solution by proton nuclear magnetic resonance spectroscopy (1H NMR). The experimental Kst value (2112 M-1) derived from the fluorimetry studies appeared to fit well to a 1:1 drug-to-cyclodextrin molar ratio according to the non-linear mathematical model. The model is particularly suitable for fluorescent compounds of which fluorescence intensity is influenced by the presence of cyclodextrins.
用于计算药物 - 环糊精络合物稳定常数(Kst)的非线性最小二乘法模型已用于荧光分析研究。通过测量在不同量的β-环糊精存在下维生素荧光强度的变化,以荧光分析法监测核黄素与β-环糊精(β-CyD)的络合作用。通过差示扫描量热法(DSC)在固态下以及通过质子核磁共振光谱法(1H NMR)在水溶液中证实了包合物的形成。根据非线性数学模型,荧光分析研究得出的实验Kst值(2112 M-1)似乎与药物与环糊精的摩尔比为1:1非常吻合。该模型特别适用于荧光强度受环糊精存在影响的荧光化合物。